“…Giray S. and Ulker Z. et al showed that this method of drug delivery reduces the side effects and increases the bioavailability of the drug, especially for poorly soluble drugs [ 11 , 12 ]. One of these compounds is mefenamic acid (MFA) which, due to several restrictions, is not recommended for use as a non-steroidal anti-inflammatory drug [ 13 , 14 , 15 ]. Therefore, Tan F. et al searched for ways to improve the form of mefenamic acid in order to repurpose it as a drug and to give developed or forgotten drugs, such as mefenamic acid, a chance to enter a new therapy field [ 16 ].…”